Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model

Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model

Xin Wang,1,* Jin Deng,2,* Chongxiang Xiong,1 Haishan Chen,1 Qin Zhou,1 Yue Xia,1 Xiaofei Shao,1 Hequn Zou1 1Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Nephrology, The First Affiliated Hospital...

Full description

Bibliographic Details
Main Authors: Wang X, Deng J, Xiong C, Chen H, Zhou Q, Xia Y, Shao X, Zou H
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Drug Design, Development and Therapy
Subjects:
hyperuricemic nephropathy
peroxisome proliferator-activated receptor-gamma
rosiglitazone
renal fibrosis
epithelial-to-mesenchymal transition
inflammation
Online Access:https://www.dovepress.com/treatment-with-a-ppar-gamma-agonist-protects-against-hyperuricemic-nep-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/treatment-with-a-ppar-gamma-agonist-protects-against-hyperuricemic-nep-peer-reviewed-article-DDDT

Similar Items